欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/7602/001
药品名称Lanreotide SUN
活性成分
    • Lanreotide 60.0 mg
剂型Solution for injection in pre-filled syringe
上市许可持有人Sun Pharmaceutical Industries (Europe) B.V. Polarisavenue 87 2132 JH Hoofddorp Netherlands
参考成员国 - 产品名称Germany (DE)
Lanreotid SUN 60 mg Injektionslösung in einer Fertigspritze
互认成员国 - 产品名称
    • Romania (RO)
      Lanreotida Terapia 60 mg soluţie injectabilă în seringă preumplută
    • Ireland (IE)
    • Slovakia (SK)
    • Austria (AT)
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Denmark (DK)
    • Hungary (HU)
    • Belgium (BE)
    • Czechia (CZ)
      Lanreotidum SUN 60 mg injekční roztok v předplněné injekční stříkačce
    • Netherlands (NL)
许可日期2024/10/24
最近更新日期2024/10/25
药物ATC编码
    • H01CB03 lanreotide
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase